Applies to Employer and ACA Marketplace plans.
Not coveredUse for weight loss (no MACE or MASH diagnosis) is explicitly excluded. Diagnosis of type 1 or type 2 diabetes without MACE or MASH is also excluded.
Policy note: Wegovy is explicitly excluded for weight loss unless the patient has a qualifying MACE or MASH diagnosis. Type 1 or type 2 diabetes without MACE or MASH also does not qualify.
Policy effective June 22, 2026 · verified June 10, 2026 · source: Cw577pv8jf · View policy document (PDF)